P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

NCT02533323 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Extranodal NK-T-Cell

Interventions

DRUG: gemcitabine
DRUG: oxaliplatin
DRUG: pegaspargase

Sponsor

Sun Yat-sen University